Available commercial kits only screen for the most common cystic fibrosis transmembrane conductance regulator (CFTR) mutations causing classic cystic fibrosis and for the Tn variant in IVS8. However, full scanning of CFTR is needed for the diagnosis of patients with cystic fibrosis or CFTR-related disorders (including congenital bilateral absence of the vas deferens) bearing rare mutations. Standard strategies for detecting point mutations rely on extensive scanning of the gene by denaturing gradient gel electrophoresis or denaturing high performance liquid chromatography, which are time-consuming. Moreover the haplotyping of IVS8-(TG)m and Tn tracts is still challenging despite several recent improvements. We have optimized both the detection of mutations and the haplotyping of IVS8 polyvariants in developing two methods: i) a rapid and robust direct sequence analysis of all exons/flanking introns of the CFTR gene based on single condition touchdown amplification/sequencing in 96-well plates, ii) a fluorescent assay which allows haplotyping of IVS8-(TG)mTn even without family linkage study. Combined with search for rare large rearrangements, this strategy detected 87.9% of CFTR defects in congenital bilateral absence of the vas deferens patients, a proportion considerably higher than those usually reported.
Introduction
Mutations in the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene are responsible for cystic fibrosis (CF, MIM 219700) and isolated congenital bilateral absence of the vas deferens (CBAVD, MIM 277180). More than 96% of the 1,500 CFTR defects reported so far are point mutations altering a few bases or only one base (http://www.genet.sickkids.on.ca), while an unknown proportion of CFTR dysfunctions are caused by large genomic rearrangements such as large deletions [1] [2] [3] [4] [5] [6] [7] . In CBAVD, 88% of patients found with two CFTR mutations carry a severe mutation (no CFTR function) in trans to a mild mutation (residual function) and 12% carry two mild mutations [8] . The vast majority of mutations in CBAVD are not detected by routine panels, designed to test up to 30 common severe CF mutations; they are scattered over the whole gene, so that all the exons and their flanking introns have to be extensively scanned to reach acceptable rates of mutation detection [8, 9] . The laborious but powerful manual DGGE (Denaturing Gradient Gel Electrophoresis) or DHPLC (Denaturing High Performance Liquid Chromatography) techniques represented until recently the most useful approaches for mutation detection in CBAVD. However, these techniques are unable to determine the length variants localized at the polypyrimidine locus upstream to the splice acceptor site of intron 8 (polyTG followed by polyT repeats) which affect the splicing efficiency of exon 9 and act as genetic modifiers of CFTR function. Five variants, (TG)9 to (TG)13, are known in the (TG)m tract, whereas up to seven different alleles have been reported in the Tn tract (common alleles with 9, 7, or 5 thymidines and rare alleles with 3 [10] , 6 [11] , 10 [12] or 11 [13] thymidines. In Caucasian populations, the frequency of IVS8-T5 allele in CBAVD patients (30%) is 6 times higher than in the general population (5%), and 34% of men with CBAVD have inherited a CFTR mutation on one gene and IVS8-T5 on the other one, making this combination the most common cause of CBAVD. The T5 variant is associated with high levels of exon 9 skipping which result in the production of a non-functional CFTR protein. However the splicing efficiency of the IVS8-T5 allele shows inter-and intra-individual variability, and its incomplete penetrance in CBAVD is largely influenced by the IVS8-(TG)m tract [14, 15] .
The determination of (TG)m repeat number is predictive of pathogenic T5 alleles [16] .
Longer TG repeats increase exon 9 skipping and raise the proportion of non functional CFTR protein, which emphasizes the importance of assessing the length not only of the Tn, but also of the (TG)m tract for diagnostic purposes. As the two repeats act in concert when modulating exon 9 inclusion or skipping in the CFTR mRNA, reliable haplotyping is an additional prerequisite for a meaningful genetic testing at this locus.
We have developed two strategies that improve both the identification of mutations and the haplotyping of IVS8 repeats. First, a method based on single condition touchdown amplification (SiCTA) in a 96-well plate format allows the rapid direct sequence analysis of all CFTR exons and flanking introns together with a portion of IVS11 and IVS19 sequences (which carry common mutations). Second, a fluorescent assay determines the length of the IVS8-(TG)m and Tn tracts of both alleles and their haplotypes even when familial segregation cannot be studied. These two simple, rapid and reliable assays can routinely be performed in a few working days.
Materials and methods

Samples
We analyzed or re-analyzed a collection of 182 samples (previous CFTR analysis of 85 of these samples had been included as part of a collaborative study [8] ). Clinical diagnosis of CBAVD was based on clinical examination with impalpable vas deferens, transrectal ultrasonography, semen analysis (volume, pH and sperm count in accordance with the World Health Organization guidelines -WHO, 1992), low concentrations of fructose and citrate.
Patients with renal abnormalities were excluded. Informed consent was obtained from all patients. DNA was extracted from peripheral blood samples by using standard procedures.
Classic protocols for analysis of CFTR mutations and IVS8-Tn alleles
A complete scan of the 27 coding/flanking sequences of the CFTR gene was performed either by DGGE or by DHPLC. In addition, two intronic mutations, 1811+1.6kbA>G in IVS11 and 3849+10kbC>T in IVS19 and variations at locus IVS8-Tn were screened by specific PCRrestriction tests. Samples showing abnormal profiles were re-amplified from genomic DNA and directly sequenced with the BigDye Terminator v1.1 cycle sequencing kit from Applied Biosystems (Warrington, UK). Samples found with only one or no CFTR disease-causing mutation were further investigated for large rearrangements such as large deletions by a semiquantitative fluorescent SQF-PCR assay previously developed in our laboratory that uses three multiplex PCRs covering the entire gene [17] . In most cases, the cis vs. trans status of the alterations was obtained by familial segregation.
New protocol for haplotyping IVS8-(TG)mTn repeats
A fluorescent assay based on three PCRs was designed. Exon 9 was first amplified using primers 9i5/9i3 described by Zielenski et al. [18] and purified according to the manufacturer's recommendations by QIAquick PCR purification kit (Qiagen , Hilden, Germany) in order to remove the unincorporated primers. An aliquot of this amplicon was then used as a template for three internal fluorescent PCRs amplifying the (TG)m and the Tn tracts separately, and the (TG)mTn tracts simultaneously (Table 1, Figure 1 ). Each amplification was carried out in a final volume of 100 µl containing PCR Buffer 10X, 20 mM of each dNTP, 10 pmol of each primer, 1U of Taq Polymerase (Applied Biosystems, Branchburg, NJ) and 1 µl of PCR1.
After an initial denaturation step at 94°C for 2 minutes, 22 cycles were performed with denaturation at 94°C for 30 sec, annealing at 55°C for 30 sec and extension at 72°C for 1 minute, followed by a final extension step at 72°C for 30 minutes. Aliquots of the 3 amplicons sequenced. For exons 6b and 9, two sequencing reactions differing at the 5'end were necessary to read both strands and avoid two polymorphic regions (IVS6a-(GATT)n and IVS8-(TG)mTn repeats, respectively). Due to its large size, exon 13 was analyzed by use of two overlapping amplicons. The sequences of the primers were derived from Zielenski et al., [18] or Fanen et al., [19] with the exception of IVS11 [20] and IVS19 [21] ; reverse primers for exons 1, 2 and 14b, forward primers for exons 2, 17a and IVS11 had to be slightly modified to ensure specific amplification. For all studied regions excepted exons 6b and 9,
PCRs and sequence reactions were performed using the same primers. The primer stocks for PCRs (a mixture of reverse and forward primers, 
Molecular haplotyping of the IVS8-(TG)mTn polymorphic locus
To validate our methodology for the determination of IVS8-(TG)mTn haplotypes, the fluorescent assay was applied to 50 CBAVD patients for which the Tn and (TG)m repeats had been previously determined by sequencing of exon 9/flanking regions. All the results were concordant, so that the remaining 132 CBAVD patients were analyzed using the fluorescent assay ( Figure 2 ); alleles ranged from (TG)9 to (TG)13 repeats, associated with T3, T5, T7, or T9 alleles. The obtained patterns showed intra and inter-run reproducibility. When DNAs were available, we confirmed IVS8-(TG)mTn haplotypes by studying the familial segregation of alleles. Three (TG)m backgrounds were associated with IVS8-T5 alleles in this population of CBAVD samples: (TG)11-T5 (7/62, 11.3%), (TG)12-T5 (49/62, 79%) and (TG)13-T5
(4/62, 6.5%). For two patients the (TG)m repeats could not be determined due to DNA shortage. Of a total of 364 CBAVD alleles, 7 (1.92%) were IVS8-(TG)11T5: three patients carried this haplotype in trans to a CF mutation (p.Asn1303Lys, p.Val562Ile, or p.Arg1162X), one was homozygous and two patients carried only this haplotype. A rare IVS8-(TG)12T3 combination that we previously found in trans to p.Phe508Cys in one patient was confirmed [15] .
SiCTA/sequencing assay validation
DNA from 10 patients already investigated for mutations by using our previous classic protocols for CFTR genetic testing were anonymized and submitted for analysis along with DNA from three wild-type subjects (CBAVD patient's partner negative for CFTR mutations). 
Discussion
Three recent studies have reported extensive CFTR sequencing in 96-well plates in patients with classical or atypical cystic fibrosis. In two assays [24, 25] the CFTR gene was studied in 32 amplicons and each PCR primer contained a M13 linker sequence ensuring a single PCR condition and the use of universal priming in cycle sequencing. All PCR primers had to be redesigned due to the presence of the M13 linker sequence. In another assay [26] , the CFTR gene was amplified in 30 amplicons with external primers and then sequenced using internal primers in 96-well plates. Redesigning all PCR primers was necessary and three amplification conditions had to be used due to different annealing temperatures of the primers.
The SiCTA/sequencing methodology described in this study presents several advantages: i) the technique is easy to set up as a routine, ii) it relies on the use of primers that have been [27, 28] .
The new fluorescent, rapid and reliable method that we report here for the determination of alleles and haplotypes at locus IVS8-(TG)mTn will also facilitate the genotyping of the sequences that modulate the splicing efficiency of exon 9 in the mRNA and/or are major determinants of the penetrance of the 5T allele in CBAVD. The importance of IVS8-(TG)mT5 determination is supported by an international collaborative study providing evidence that the odds of pathogenicity are 28 and 34 times greater for (TG)12T5 and (TG)13T5, respectively, than for (TG)11T5 [16] . The use of allele-specific oligonucleotide (ASO) hybridization, reverse hybridization or PCR with specific primers for the T5, T7 or T9
can result in misdiagnosis, not only in the assignation of the most common alleles (7, 9, or 5T) but also because of the inability to detect other variants than the most frequent T5, T7 and T9. Despite the fact that IVS8-T3 [10] , T6 [11] , T10 [12] , T11 [13] and IVS8-(TG)8 [23] appear to be rare in Caucasian populations, our technique allows an easy detection of all different alleles described so far at IVS8-Tn (3, 5, 6, 7, 9, 10 and 11 thymidines) and -(TG)m (8 to 13 repeats) loci. Our fluorescent haplotyping method presents similar advantages as those previously described using a direct sequencing method [23] . It allows i) to determine IVS8-(TG)mTn haplotypes even without family linkage study, ii) to be used either as primary or confirmatory test. However, for familial segregation or population studies, the fluorescent haplotyping method is more rapid to implement and easier to interpret, thereby saving a considerable amount of time and effort. Direct molecular haplotyping of the IVS8-(TG)mTn repeats by melting curve analysis of hybridization probes was recently described [12] . This method is particularly rapid but, unfortunately, (TG)12T5 and (TG)13T5 haplotypes, that are of particular interest in CBAVD patients, showed indistinguishable melting temperatures and could not be clearly identified [29] .
Large rearrangements account for 16-20% of unidentified alleles in classic cystic fibrosis [1, 4, 5] (our unpublished results). In our CBAVD series, only two patients (1.1%) have been found to carry a large gene deletion [17] , which represents 4.8% of alleles negative for a CFTR point mutation, which is in accordance with the results of another study [7] . Gross alterations seem to be less frequent in CBAVD than in CF, which is relevant with the lower proportion of severe alleles in CBAVD than in CF. So far only eight cases with a large rearrangement have been reported in CBAVD [2, 5, 7, 17] .
By combining direct sequencing, fluorescent haplotyping and SQF-PCR for large rearrangements, we were able to identify at least one CBAVD-causing mutation in 92.3% of the 182 patients analyzed in this series, including 83.5% with two alleles fully characterized, which is the highest rate reported so far. For the 16 patients with only one mutation, the implication of the CFTR gene is still unclear: do they carry a deep mutation in introns not investigated by techniques applied to genomic DNA? Is heterozygosity for a CFTR defect a predisposing factor for CBAVD? For the 14 patients negative for point mutation, large rearrangement, or predisposing haplotype, the link between CBAVD and CFTR gene is questionable.
The procedure can also be applied to partners of affected patients (CF or CBAVD) for whom the CFTR gene needs to be entirely scanned. Moreover, it is of particular interest for fetuses when hyperechogenic bowel or ascities suggestive of CF is prenatally detected by ultrasound during the 2 nd or 3 rd trimester of pregnancy. In such emergency situation, the common known mutations are first screened using a commercially available kit. If one of the parents carries a mutation that has been transmitted to the fetus, the entire CFTR gene has to be scanned for the second mutation. Using SiCTA/sequencing, the whole gene can be analyzed for both known and private mutations within a few days. repeats are slippage prone. From our experience, the interpretation rule is to consider only the highest and the last peak (in black). (a) The forward primers of exon 2 and IVS11 were adapted from Zielenski et al. [18] and
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Chillon et al. [20] respectively.
(b) The 5' end of exons 6b and 9 were sequenced using 2 different forward primers to avoid the polymorphic regions (IVS6a-(GATT)n and IVS8-(TG)mTn tracts respectively).
(c) Exon 13 was amplified in 2 overlapping amplicons Ex 13(5') and Ex13(3') due to its large size.
(d) The reverse primer of exon 15 designed by Fanen et al. [19] was deprived of the GC tail. 
